Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review

被引：0

作者：

Vincent Dochez

Hélène Caillon

Edouard Vaucel

Jérôme Dimet

Norbert Winer

Guillaume Ducarme

机构：

[1] CHU de Nantes,Service de Gynécologie

[2] CHU de Nantes,Obstétrique

[3] Centre Hospitalier Départemental Vendée,Service de Biochimie

[4] Centre Hospitalier Départemental Vendée,Centre de recherche clinique

来源：

Journal of Ovarian Research | / 12卷

关键词：

HE4; CA125; ROMA; RMI; Ovarian cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Ovarian cancer is the 5th leading cause of death for women with cancer worldwide. In more than 70% of cases, it is only diagnosed at an advanced stage. Our study aims to give an update on the biological markers for diagnosing ovarian cancer, specifically HE4, CA 125, RMI and ROMA algorithms.

引用

共 50 条

[41] Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
Hamed, Elham O.
Ahmed, Hydi
Sedeek, Osama B.
Mohammed, Abeer M.
Abd-Alla, Ali A.
Ghaffar, Hazem M. Abdel
DIAGNOSTIC PATHOLOGY, 2013, 8
[42] The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis
Li, Y.
Wang, Z. -C
Luo, L.
Mu, C. -Y.
Xu, J.
Feng, Q.
Li, S. -B.
Gu, B.
Ma, P.
Lan, T.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (02) : 604 - 610
[43] Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer
Kristjansdottir, Bjorg
Levan, Kristina
Partheen, Karolina
Sundfeldt, Karin
GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 52 - 58
[44] Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125
Shah, Chirag A.
Lowe, Kimberly A.
Paley, Pamela
Wallace, Erin
Anderson, Garnet L.
McIntosh, Martin W.
Andersen, M. Robyn
Scholler, Nathalie
Bergan, Lindsay A.
Thorpe, Jason D.
Urban, Nicole
Drescher, Charles W.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (05) : 1365 - 1372
[45] Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Jorge A. Alegría-Baños
José C. Jiménez-López
Arely Vergara-Castañeda
David F. Cantú de León
Alejandro Mohar-Betancourt
Delia Pérez-Montiel
Gisela Sánchez-Domínguez
Mariana García-Villarejo
César Olivares-Pérez
Ángel Hernández-Constantino
Acitlalin González-Santiago
Miguel Clara-Altamirano
Liz Arela-Quispe
Diddier Prada-Ortega
Journal of Ovarian Research, 14
[46] THE UTILITY OF HE4, CA125 AND ROMA IN DIFFER ENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT GYNEACOLOGICAL DISEASES
Escudero, J. M.
Auge, J. M.
Filella, X.
Foj, L.
Molina, R.
TUMOR BIOLOGY, 2010, 31 : S58 - S59
[47] Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer
Alegria-Banos, Jorge A.
Jimenez-Lopez, Jose C.
Vergara-Castaneda, Arely
Cantu de Leon, David F.
Mohar-Betancourt, Alejandro
Perez-Montiel, Delia
Sanchez-Dominguez, Gisela
Garcia-Villarejo, Mariana
Olivares-Perez, Cesar
Hernandez-Constantino, Angel
Gonzalez-Santiago, Acitlalin
Clara-Altamirano, Miguel
Arela-Quispe, Liz
Prada-Ortega, Diddier
JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
[48] A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer
Melike Bilgi Kamaç
Muhammed Altun
Merve Yilmaz
Mustafa Kemal Sezgintürk
Analytical and Bioanalytical Chemistry, 2023, 415 : 1709 - 1718
[49] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer
Wei, Su
Li, Hui
Zhang, Bei
BIOMEDICAL REPORTS, 2016, 5 (01) : 41 - 44
[50] CA125、HE4、ROMA及RMI在附件包块诊断中的应用价值
王雅贤
陈琼华
中国实用妇科与产科杂志, 2020, 36 (12) : 1163 - 1167

← 1 2 3 4 5 →